ARCHIVES

James Doroshow Named NCI Deputy Director, Clinical Research

This article is from The Cancer Letter archive.

Vol. 37 No. 23 | June 10, 2011

Download PDF Visit The Full Archive

Related Articles

$1.5 Million In Direct Costs Is Proposed Core Grant Requirement

July 12, 1991

President’s Surgery Stirs Interest In Colon Cancer Exams

July 26, 1985

FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy

March 21, 1997

Phase II Study Of Pfizer Drug Meets Primary Endpoint

April 24, 2009

Surveillance Following Surgery Sufficient in Stage I Seminoma

May 31, 2013

NCI Appropriations Still Hung Up

September 30, 1977